Meier-Ruge, W. , Emmenegger, H., Gycax, P., Iwangoff, Chr., Cerletti, A.: About the pathophysiology and therapy of cerebral insufficiency. A contribution to the experimental gerontology of the brain, in Altem II. Internat. Sympos. Exper. Gerontol. Edited by D. Platt. Stuttgart/New York, Schattauer , 1974, pp. 153-167.
5.
Nascimento, O.J.M. , Conti, L.M.Z.: Uso da Cinarizina 75 mg em pacientes com insuficiência vascular cerebral crônica. F. Méd. (BR) , 8: 91, 1980.
6.
Pacheco E.Silva, A.: Estudo sôbre a ação da hydergina nas insuficiências vasculares cerebrais em pacientes hipertensos. Hospital, 78: July 1970.
7.
Aspesi, N.V. , Mazzaferro, A., Molina, N., De Sanches, M.M.V.: Ação da Cinnarizine sobre a arteriosclerose cerebral. Folha Méd., 64: February 1972.
8.
Cannoni, Pr. : Interêt de l'utilisation d'une drogue vaso-dilatatrice puissante dans les syndromes neuro-otologiques ischemiques. Cahiers d'O.R.L., 8: 1978.
9.
Fracassi, M.J. , Fracassi, C.T., Vital, F.: Neustra experiencia con un nuevo fármaco, la Cinnarizine R 516, en pacientes con insuficiencia circulatoria cerebral . Sem. Méd., 134: March 1969.
10.
Horn, R.: Influencia do Stugeron 75 mg sobre a capacidade de concentração: Estudo duplo-cego comparativo. Folha Méd., 1976.
11.
Chermet, J. : Étude pharmacologique de l'activité du LL 1656 par des artériographies périphériques. Méd. Prat., 609: 27, 1976.
12.
Cloarec, M. : Traitement des troubles circulatoires provoqués par l'amantadine. Méd. Prat., 651: 86, 1977.
13.
Ehringer, H., Konecny, U., Ingerle, H., Minar, E., Wiethoff, E.Effect of Buflomedil in perfusion of the extremities in peripheral vascular disease. Presented at the Congress on Microculation and Ischemic Vascular Diseases—Advances in Diagnosis and Therapy. München, November 28, 29, 1980.
14.
Endrich, B., Schosser, R., Beyer, J., Martin, E., Member, K.: Influence of Buflomedil on total O2-consumption, regional blood flow and tissue pO2. Presented at the Congress on Microcirculation and Ischemic Vascular Diseases—Advances in Diagnosis and Therapy. München, November 28, 29, 1980.
15.
Fagrell, B., Hermansson, L.I.: The effect of Buflomedil on skin microcirculation in patients with acral gangrene . Presented at the Congress on Microcirculation and Ischemic Vascular Diseases—Advances in Diagnosis and Therapy. München, November 28, 29, 1980.
16.
Lucas, M.A., and Cerdeyra, C.: Buflomedil vs. Naftidrofuryl: ergometric comparative evaluation in patients with intermittent claudication. Presented at the Congress on Microcirculation and Ischemic Vascular Diseases—Advances in Diagnosis and Therapy. München, November 28, 29, 1980.
17.
Cunha Bastos, A., Celestino, C.A., Landi de Almeida , S.M.: Avaliação da eficácia clinica do Buflomedil no Tratamento de Pacientes Portadores de Arteriosclerose Senil. F. Méd. (BR), 80: 73, 1980.
18.
Liss, R.: Vasoactive effect of Loftyl. Presented at the Second World Congress for Microcirculation. San Diego, California , July 1979.
19.
Touya, E., Mut, F., Simini, F., Garcia, F., Rodriguez, D.: Cerebral Blood Flow in Diffuse Cerebrovascular disease. Basal and postadministration of vasoactive drug measurements. Presented at the Congress on Microcirculation and Ischemic Vascular Diseases—Advances in Diagnosis and Therapy. München, November 28, 29, 1980.
20.
Badmin, J.A. , Kumar, J.L., Mann, W.C.: Determination of Buflomedil Hydrochroride (2',4',6'-trimethoxy 4 (pyrrolidinyl) butyrophenone hydrochroride) by reversed-phase high-performance liquid chromatography. J. Chromatogr., 172: 319, 1979.
21.
Fredj, G., Clenet, M., Rousselet, F.: Dosage du Buflomedil dans les milieux biologiques. Determination des differents paramètres pharmacocinétiques. Thérapie, 33: 321, 1978.
22.
Godfraind, T., and Kara, A.: The role of calcium in the action of drugs on vascular smooth muscle. Arch. Int. Pharmacodyn., 196: 1972.
23.
Wurzinger, L.J. : Effects of Buflomedil on spontaneous and adrenaline induced platelet aggregation in vitro and after intravenous application under anticoagulation. Presented at the Congress on Microcirculation and Ischemic Vascular Diseases—Advances in Diagnosis and Therapy. München, November 28, 29, 1980.
24.
Data on file at Abbott Laboratories. (to be published).